The Importance of the Assessment of Quality of Life in Glaucoma Patients by Pelčić, Goran et al.
73
JAHR  Vol. 8/1  No. 15  2017
Review Article / Pregledni znanstveni članak
Received / Zaprimljen: 15. 5. 2017.
Goran Pelčić*, Nikša Perić, Gordana Pelčić**
The Importance of the Assessment of 
Quality of Life in Glaucoma Patients
ABSTRACT
Glaucoma is a chronic, progressive eye disorder that can lead to visual impairment and 
blindness. The projection of glaucoma prevalence in the world suggests that in 2020, 79,6 
million of people will have glaucoma, 11,2 million of them will be bilaterally blind. The 
chronic disease, such as glaucoma, affects the different roles of a patient in everyday life and 
his/her well-being. Quality of Life (QoL) helps to define the inability of performing specific 
task that is most important to patient. Patients’ perspective on their visual impairment and 
well-being are essential in the planning of management of glaucoma. The assessment of QoL 
should be standard procedure in the management of glaucoma patients. In clinical practice 
it should represent a gold standard in the care of chronic patients and a proof of fulfilling the 
patients’ rights. The assessments of QoL should serve as a tool for good clinical practice, for 
respecting the patients’ rights, and respect for the value of human life in general.  
Keywords: Quality of life, glaucoma, patients’ perspective, rights of the patients. 
Introduction
Glaucoma is a chronic, progressive eye disorder that can lead to visual impairment 
and blindness (1,2). In the early stage glaucoma is often asymptomatic, therefore 
undiagnosed chronic disease with irreversible consequences on the vision, physical, 
psychical and social life of the patients. It is assumed that only half of glaucoma 
patients in developed countries are aware of their disease (3), in comparison 
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to 90% of unaware glaucoma patients in the developing countries. Glaucoma is 
important public health issue of 21st century (4,5,6,7). The projection of glaucoma 
prevalence in the world suggests that in 2020, 79,6 million of people will have 
glaucoma and 11,2 million of them will be bilaterally blind (6,8). As Bourne (2,9,6) 
suggested, many papers started with the sentence that ‘‘Glaucoma is the second 
leading cause of vision loss in the world’’ that actually could represent awareness 
of researchers worldwide regarding the seriousness of glaucoma’s consequences. The 
ophthalmologists worldwide are focused more on how to maintain the intraocular 
pressure (IOP) within the normal values or how to preserve the visual function of 
their patients, while the patients are focused on their ability to fulfill everyday’s tasks 
and roles in everyday’s lives (family, business or social roles). The chronic disease, such 
glaucoma is, effects the different roles of patients and well-being of the patients too. 
Perspectives of ophthalmologist and perspectives of glaucoma patients regarding the 
different important issues in management of glaucoma sometimes do not coincide 
(10). Ophthalmologists should be aware of the importance of well-being for the 
glaucoma patients, and should estimate it through their work. Measuring the quality 
of life (QoL) related to the health and vision can assess the well-being of patients. 
One of the most important aims of the glaucoma management is preservation of 
QoL of glaucoma patients.
Glaucoma 
Glaucoma is a chronic neurodegenerative disorder that could lead to irreversible 
changes of retinal ganglion cells and loss of optic nerve cells (7). If not treated 
properly and timely, it could cause severe vision impairment and blindness. 
Generally, glaucoma mostly affects people over 40 years of age. Visual impairments 
are the highest in older population (11) with an effect on visual function and general 
well-being. The demographic characteristics in the world suggest that along with the 
population ageing there is a higher prevalence of glaucoma (1,12,13,14). On the 
other hand, the worldwide trend is an increasing age of working active population. It 
is assumed that there will be a great number of working active population suffering 
from glaucoma and its’ consequences on working ability and everyday functioning. 
The review of literature suggests that advanced glaucoma degrades the patient’s 
general health, Quality of life (QoL), and vision related to quality of life (2,10,15). 
The chronic disease has negative impact on patients’ physical, emotional and social 
aspects of life (11,16).
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Quality of life 
One of the most important aims of the glaucoma management is preservation of 
glaucoma patients’ QoL (16,17,18,19,20,21). The goal of the ophthalmologist is 
prevention of the loss of health related quality of life (HRQOL).
QoL could be defined as person’s own estimation of physical, psychological or social 
well-being (17,19). It is important to assess the multidimensional characteristics of 
QoL such as physical parameters (sign of illness and therapy), functional (ability to 
move and mobility), social (interpersonal contact and relationships) or psychological 
(mental health and stability) (22,23,24).
The instruments used to assess QoL identify presence or absence or severity and 
frequency of different types of symptoms (16). But they are not useful for the 
identification of the priority of particular symptoms, which mostly disturbs the 
patient. The ability to work, drive the car, do the sports, to be active in social life 
are indirect signs of successful glaucoma therapy. These elements contribute to 
preservation of good QoL. 
QoL is not a constant value, it differs in one patient over time (19) or depending on 
the situation (25). QoL of two persons suffering from the same diagnosis is different. 
Various factors can contribute to QoL, such as culture, social environment, or the 
patients’ expectations in life. 
The researcher’s goal is to choose an instrument to measure QoL (26). Mainly, those 
instruments are self-reported or interview administered questionnaires (19). Health 
related questionnaires, which are used in glaucoma patients for assessing QoL, 
could be divided in general health questionnaires and disease related questionnaires 
(17,19,22).  
In this paper we will put an emphasis on disease related questionnaires or vision-
specific QoL questionnaires in glaucoma patients.
Instruments for assessing the QoL in glaucoma patients
The Activities of Daily Scale (ADVS) originally was addressed to cataract patients. 
ADVS is made of 22 questions divided in 5 subgroups (near vision, distant vision, 
glare disability, daytime driving and night driving) (19). 
The Visual Function Index (VF-14) originally was designed to assess functional 
impairment in patients with cataract (19).
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The Visual Activities Questionnaire (VAQ) is made of 33 questions divided in 10 
subgroups. The aim of VAQ is to assess the difficulties in everyday’s visual problem 
in older glaucoma patients (19). 
The Impact of Vision Impairment (IVI) consists of 32 questions regarding the 
impact of visual impairment on everyday life experience (19).
The National Eye Institute Visual Function Questionnaire (NEI-VFQ) consists of 
25 questions regarding the impact of different ocular problems on everyday vision 
functioning (17,19). 
The Glaucoma Symptoms Scale (GSS) is constructed to assess 10 symptoms that 
glaucoma patients experience (visual and non-visual symptoms) (19).
The Viswanathan Questionnaire is constructed of 10 questions with yes or no 
responses regarding the ability to find a lost object, or climb up the stairs, or bump 
into the objects (19).
The Glaucoma Quality of Life (GQL-15) is composed of 15 questions for the 
purpose of assessing the stage of functional disability (17,19).
Glaucoma Symptom Identifier (GSI) is constructed to identify various glaucoma 
symptoms with their impact on QoL (17). 
Independent Mobility Questionnaire (IMQ) is constructed for measurement of 
patients’ ability for independent mobility (17). 
Comparison of Ophthalmic Medications for Tolerability (COMTOL) is constructed 
for use in clinical trials in order to compare the side effects of medication therapy and 
impact on QoL (17).
Treatment Satisfaction Survey-Intraocular Pressure (TSS-IOP) is designed for 
assessment of patient’s satisfaction regarding the different aspects of topical 
antiglaucoma medication. 
In general, patient-reported outcomes can be divided in three categories: those which 
address functional status regarding the vision; those which assess QoL in general, and 
the third one which detect other issues connected to the disease and treatment (17).
Until today there are no ideal questionnaires for assessing QoL in glaucoma patients. 
Glaucoma Patients’ perspectives on the QoL 
Difficulty and inability to perform daily activities often bring the patient to the 
ophthalmologist’s office before the patient actually knew that he has glaucoma. 
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Irreversible changes of optic nerve axon and retinal ganglion cells result in inability 
to perform many visual demanding tasks (27), such as difficulties while reading, 
writing, dressing, traveling in glaucoma patients (24). Functional loss, anxiety due 
to diagnosis, the costs of treatment, or inconveniences might also have negative 
impact on QoL (28). Patients usually report bumping into the things, difficulties in 
climbing stairs, etc. 
QoL helps to define the inability of performing specific task that is most important 
to patient. This is very important moment in planning the management of glaucoma. 
Because of that, the assessing of QoL in clinical practice is important for allocation of 
limited resources and for therapy planning of particular patient (16). 
Even a moderate visual impairment leads to deterioration of patient’s QoL (2,29) 
regardless of the primary ocular diagnosis. Moderate visual impairment can lead to 
deterioration of visual impairment, and can have a negative impact on emotional 
well, increased functional disabilities. These findings were collected from the patients’ 
perspectives, because of their negative impact on patients’ well-being. They suggest 
that even the patients with moderate visual impairment should undergo further 
evaluation of their vision health status. Without exploring the patients’ perspective 
regarding the moderate visual impairment, ophthalmologist might postpone further 
evaluation of vision that could lead to more serious deterioration of visual impairment 
with the consequences on emotional status, family, business, or social functioning. 
Why QoL instruments should be assessed in clinical practice 
regarding glaucoma patients?
The assessment of QoL in glaucoma patients, regardless of the type of QoL 
questionnaires, has multiple benefits on glaucoma patients’ well-being. It reminds 
ophthalmologist that his/her perspective on success of glaucoma treatment might 
differ from patients’ perspectives. It reminds patients of glaucoma consequences on 
everyday tasks that he/her is not able to perform anymore. It recalls that adherence 
to the lifelong therapy is important for patient functioning and fulfilling life tasks in 
family, business or social environment. 
There are wide possibilities available to assess the QoL in glaucoma patients (7,19) but 
it seems that these possibilities are mostly reserved for the researches’ purposes and 
not for the clinical practice. On the other hand, the perception of patients suggests 
the necessity of including the assessment of QoL in daily work of ophthalmologists. 
As Waisbourd suggests, every ophthalmologist should ask him/herself how he/she 
can preserve or even improve the health and well-being of their patients (7). The 
ophthalmologists’ interest should not focus only on the value of intraocular pressure 
JAHR  Vol. 8/1  No. 15  2017
78
or on visual field loss, it should also focus on the possibilities of patients to perform 
different daily activities. The patients’ reports regarding difficulties in daily activities 
could have an impact on clinical decision making and antiglaucoma therapy planning. 
If these elements are not taken into account, the right of the patients to proper care 
could be disturbed. 
On the other hand, assessing QoL (health related or vision related) instruments in 
undiagnosed glaucoma patients could serve as a diagnostic tool. McKean-Cowdin et 
all (2) performed study in which they assessed health related QoL instrument among 
the participants who were not aware of their glaucoma diagnosis at that time. Among 
the 6357 participants, 291 were identified with open angle glaucoma (OAG), 75% 
of them were diagnosed glaucoma for the first time. Those diagnosed glaucoma 
for the first time had modest levels of vision loss, but lower health related QoL. 
It could be assumed that assessing HRQoL instruments in settings such as general 
medicine office or in general ophthalmological office might serve as a screening tool 
for glaucoma in the patients who have lower HRQoL.  
Bioethical approach regarding QoL
If QoL is determined by well-being, which is a more subjective factor, then it is 
difficult to accurately define QoL (30). There are several values that are gained by 
assessing QoL:
a.  The progression of illness and success of therapy could be measured 
b.   Analyzing the database of the previously obtained QoL data, physician can 
choose the best appropriate therapy for the present patient
c.   The databases can provide the information regarding side effects of specific 
treatment
d.  Assessment of the cost effectiveness of certain therapy 
The assessment of QoL has a dangerous side, as is the case where somebody’s 
subjective perception of QoL is low, this could lead to value QoL as the quality of 
human person with consequent discussion of whether this person should receive 
medical treatment or is it worth living (30). 
Addressing the participants of the Study Congress of the Pontifical Academy for 
Life “Quality of life and ethics of health“, Pope John Paul II said that theme „…is 
of the greatest ethical and cultural importance for both developed and developing 
societies“ (31). He emphasizes the danger of understanding the QoL through the 
health economics, consumerism, physical beauty and pleasure, while forgetting the 
essence of QoL, such as interpersonal, spiritual, and religious existence. 
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The utilitarian perspectives
Pragmatic utilitarian perspectives evaluate QoL as minimizing the pain and the 
economic costs (32). Utilitarian perspectives are based on the ethic of consequentiality. 
There are human lives worth living and those which are not worth living. There 
are different measurements, such as minimum intellectual capacity self-awareness, 
self-control, orientation in time and spaces, capacity to relate to others, interest for 
others, capacity to communicate. Other measure can be hedonistic perspectives.  
The utility theory, developed in 1940 and implemented in health care by the 1970s, 
associate QoL with health care. Utility analysis enabled objective evaluation of QoL 
in health care, especially associated with visual field loss (10,33,34). A utility value of 
1.0 correlates with good health, while a value of 0.0 correlates with death. The higher 
the utility value, the better the QoL is. Regarding the ophthalmology, utility values 
decrease in correlation with visual loss (10).
As we represent, there are possibilities of different perspectives of patients and 
ophthalmologists regarding the glaucoma patients’ well-being. An appropriate 
approach to glaucoma patient necessary includes patient’s perception of his/her well-
being and subjective self-reported measures together with the clinical measures, and 
performed based measures (7). A holistic, complete approach to a patient, in this 
case to a glaucoma patient, needs time. Because of the shortage of time, health care 
policies, unclear regulation, or lack of the regulation regarding implementation of 
the health care, the glaucoma patient often does not receive holistic approach from 
his/her ophthalmologist. In the bioethical sense, the plan for assessment of glaucoma 
patients should include all above mentioned elements. Many authors agree that 
consideration of patients’ perspectives and preferences should be gold standard in 
establishing the impairment caused by a health state and eventual improvement in 
QoL (10,35).
The health care decisions often have to be individualized. Two patients might have 
the similar score in Qol measurements but with different perceptions of one’s own 
well-being or the patients’ and physicians’ perspectives on the same results could have 
opposite perception of patients’ health status and well-being. As well, the choices 
between possible outcomes may be viewed differently by different patients (35) or 
physicians. 
Conclusion 
Awareness of the importance of QoL and its’ assessment in glaucoma patients goes 
beyond the research and statistics. The assessment of QoL of glaucoma patients should 
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be the standard procedure in clinical practice, the base for future therapy planning. 
The QoL assessment is a way to incorporate patients’ perspectives on their well-
being into the future therapy planning. It is the guarantee to incorporate patients’ 
rights in everyday practice. To prevent a global pandemic of glaucoma patients, the 
assessment of health and vision related QoL should be considered as a diagnostic tool 
for glaucoma patients. The QoL assessment is generally of great value to patients but 
could be interpreted from an unethical perspective and unethical reasons. 
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Važnost ispitivanja kvalitete života kod 
pacijenata oboljelih od glaukoma
SAŽETAK 
Glaukom je kronična, progresivna očna bolest koja može dovesti do oštećenja vida i sljepoće. 
Projekcije prevalencije glaukoma u svijetu sugeriraju kako će 2020. godine 79,6 milijuna 
ljudi imati glaukom, dok će 11,2 milijuna biti obostrano slijepo. Kronična bolest, kao što je 
glaukom, utječe na različite životne uloge oboljelog i njegovu dobrobit. Određivanje kvalitete 
života (QoL) pomaže odrediti koje svakodnevne zadatke pacijent ne može izvršiti, a za njega 
su najvažniji. Pacijentova perspektiva na oštećenje vida i njegovu dobrobit esencijalni je 
element u planiranju liječenja. Ispitivanje kvalitete života trebalo bi biti standardni postupak 
u skrbi o pacijentu s glaukomom. Ispitivanje QoL-a u kliničkoj praksi trebalo bi predstavljati 
zlatni standard u skrbi o kroničnom pacijentu i poštovanju njegovih prava. Ispitivanje QoL-a 
trebalo bi služiti kao sredstvo dobre kliničke prakse i poštovanja prava pacijenata, kao i 
poštovanja ljudskog života općenito. 
Ključne riječi: kvaliteta života, glaukom, perspektiva pacijenta, prava pacijenata.
